GENinCode (LON:GENI) Stock Price Down 3.3% – Here’s What Happened

GENinCode Plc (LON:GENI) was down 3.3% during trading on Wednesday . The company traded as low as GBX 2.10 and last traded at GBX 2.37. Approximately 1,282,790 shares changed hands during trading, an increase of 53% from the average daily volume of 839,947 shares. The stock had previously closed at GBX 2.45.

GENinCode Trading Down 1.7%

The stock’s 50-day simple moving average is GBX 2.74 and its two-hundred day simple moving average is GBX 2.45. The company has a debt-to-equity ratio of 9.28, a current ratio of 2.60 and a quick ratio of 15.89. The firm has a market capitalization of £6.34 million, a P/E ratio of -0.94 and a beta of 0.66.

GENinCode (LON:GENI) last released its earnings results on Tuesday, September 30th. The company reported GBX (1.19) earnings per share for the quarter. GENinCode had a negative net margin of 228.70% and a negative return on equity of 289.74%. Equities research analysts expect that GENinCode Plc will post -7.1299999 EPS for the current year.

About GENinCode

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.